Eli Lilly & Co. (LLY) volatility elevated into Alzheimer's data

Eli Lilly & Co. (NYSE: LLY) November weekly call option implied volatility is at 78, December is at 70, January is at 49; compared to its 52-week range of 14 to 64 into the solanezumab data for Alzheimer's.

You May Also Be Interested In

• Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
• Bessent on bonds: buyback could be more than 4 billion - CNBC
• TeraWulf (WULF) August 10 calls, September 12 puts, October 9 puts active